Literature DB >> 26388050

The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity.

Tatsuo Kanda1, Reina Sasaki2, Shingo Nakamoto3, Yuki Haga2, Masato Nakamura2, Hiroshi Shirasawa4, Hiroaki Okamoto5, Osamu Yokosuka2.   

Abstract

Epigenetics plays a role in the regulation of gene expression. Epigenetic changes control gene expression at the transcriptional level. Our previous study suggested that the La protein, which is mainly localized in the nucleus, was associated with hepatitis A virus (HAV) internal ribosomal entry site (IRES)-mediated translation and HAV replication. The aim of this study was to investigate whether epigenetic compounds have effects on HAV IRES-mediated translation and HAV replication. Sirtinol, a sirtuin inhibitor, inhibited HAV IRES-mediated translation in COS7-HAV-IRES cells. Treatment with 10 μM sirtinol resulted in a significant reduction in the intracellular RNA levels of HAV HA11-1299 genotype IIIA in Huh7 cells. Epigenetic treatment with a sirtuin inhibitor may represent a new treatment option for HAV infection. In conclusion, epigenetic control was involved in HAV IRES-dependent translation and HAV replication. Special attention should also be paid to underlying viral diseases in the clinical use of epigenetic treatments for malignancies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HAV; IRES; JNJ-7706621; Sirtinol

Mesh:

Substances:

Year:  2015        PMID: 26388050     DOI: 10.1016/j.bbrc.2015.09.083

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis.

Authors:  Debajit Dey; Manidipa Banerjee
Journal:  J Clin Transl Hepatol       Date:  2016-09-25

2.  Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2.

Authors:  Mingming Zhang; Yida Pan; Robert G Dorfman; Yuyao Yin; Qian Zhou; Shan Huang; Jie Liu; Shimin Zhao
Journal:  Sci Rep       Date:  2017-02-28       Impact factor: 4.379

3.  Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication.

Authors:  Xia Jiang; Tatsuo Kanda; Yuki Haga; Reina Sasaki; Masato Nakamura; Shuang Wu; Shingo Nakamoto; Hiroshi Shirasawa; Hiroaki Okamoto; Osamu Yokosuka
Journal:  Exp Ther Med       Date:  2017-04-28       Impact factor: 2.447

4.  Sirtinol regulates the balance of Th17/Treg to prevent allograft rejection.

Authors:  Qing Ye; Mingjian Zhang; Yang Wang; Shangxi Fu; Shu Han; Liming Wang; Quanxing Wang
Journal:  Cell Biosci       Date:  2017-10-27       Impact factor: 7.133

Review 5.  Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Naoki Matsumoto; Masahiro Ogawa; Mitsuhiko Moriyama
Journal:  Viruses       Date:  2020-05-12       Impact factor: 5.048

6.  Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression.

Authors:  Nan Nwe Win; Tatsuo Kanda; Shingo Nakamoto; Mitsuhiko Moriyama; Xia Jiang; Akiko Suganami; Yutaka Tamura; Hiroaki Okamoto; Hiroshi Shirasawa
Journal:  Int J Med Sci       Date:  2018-07-30       Impact factor: 3.738

7.  SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism.

Authors:  Yang Li; Mingming Zhang; Robert G Dorfman; Yida Pan; Dehua Tang; Lei Xu; Zhenguo Zhao; Qian Zhou; Lixing Zhou; Yuming Wang; Yuyao Yin; Shanshan Shen; Bo Kong; Helmut Friess; Shimin Zhao; Lei Wang; Xiaoping Zou
Journal:  Neoplasia       Date:  2018-06-17       Impact factor: 5.715

8.  The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming.

Authors:  Lei Xu; Lei Wang; Lixing Zhou; Robert Gregory Dorfman; Yida Pan; Dehua Tang; Yuming Wang; Yuyao Yin; Chengfei Jiang; Xiaoping Zou; Jianlin Wu; Mingming Zhang
Journal:  Neoplasia       Date:  2019-03-29       Impact factor: 5.715

9.  Sirtuin Inhibitors Are Broadly Antiviral against Arboviruses.

Authors:  Brent A Hackett; Mark Dittmar; Elisha Segrist; Nathan Pittenger; Julie To; Trevor Griesman; Beth Gordesky-Gold; David C Schultz; Sara Cherry
Journal:  mBio       Date:  2019-07-09       Impact factor: 7.867

Review 10.  Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Hiroshi Takahashi; Taku Mizutani; Naoki Matsumoto; Kazushige Nirei; Mitsuhiko Moriyama
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.